Glenzocimab

DB16175InvestigationalProtein Based Therapies

Glenzocimab: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin g1, anti-(human platetet glycoprotein vi) fab fragment (humanized monoclonal act017 .gamma.1-chain), disulfide with humanized monoclonal act017 .kappa.-chain
Code names
ACT-017

Resolves to

Compound
UNII58D9BCH9O0CAS2101829-58-5
Targets
Q9HCN6GP6

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Glenzocimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In